Branched-chain amino acid metabolism in heart disease: An epiphenomenon or a real culprit?

Cardiovascular Research

Volumn 90, Issue 2, 2011, Pages 220-223

  Huang, Ying ^a   Zhou, Meiyi ^a   Sun, Haipeng ^a,b   Wang, Yibin ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Branched chain amino acid; Heart failure; PP2Cm

Indexed keywords

BRANCHED CHAIN AMINO ACID; BRANCHED CHAIN KETO ACID; ISOLEUCINE; LEUCINE; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHOPROTEIN PHOSPHATASE 2; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; VALINE;

AMINO ACID METABOLISM; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR AUTOREGULATION; CELL FUNCTION; CELL VIABILITY; CITRIC ACID CYCLE; CORONARY ARTERY DISEASE; GENETIC MODEL; HEART DEVELOPMENT; HEART DISEASE; HEART FAILURE; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

AMINO ACIDS, BRANCHED-CHAIN; ANIMALS; ENERGY METABOLISM; HEART FAILURE; HUMANS; PHOSPHOPROTEIN PHOSPHATASES; VENTRICULAR REMODELING;

EID: 79955456000     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr070     Document Type: Article

References (40)

1. Bing RJ, Siegel A, Vitale A, Balboni F, Sparks E, Taeschler M et al. Metabolic studies on the human heart in vivo. I. Studies on carbohydrate metabolism ofthe human heart. Am J Med 1953;15:284-296.
2. Ingwall JS. Energy metabolism in heart failure and remodelling. Cardiovasc Res 2009;81: 412-419.
3. Revenco D, Morgan JP. Metabolic modulation and cellular therapy of cardiac dysfunc-tion and failure. J Cell Mol Med 2009;13:811-825.
4. van Bilsen M, van Nieuwenhoven FA, van der Vusse GJ. Metabolic remodelling ofthe failing heart: beneficial or detrimental? Cardiovasc Res 2009;81:420-428.
5. Horowitz JD, Chirkov YY, Kennedy JA, Sverdlov AL Modulation of myocardial metabolism: an emerging therapeutic principle. Curr Opin Cardiol 2010;25:329-334.
6. Guertl B, Noehammer C, Hoefler G. Metabolic cardiomyopathies. Int J Exp Pathol 2000;81:349-372. (Pubitemid 32291178)
7. Harper AE, Miller RH, Block KP. Branched-chain amino acid metabolism. Annu Rev Nutr 1984;4:409-454.
8. Baquet A, Lavoinne A, Hue L Comparison of the effects of various amino acids on glycogen synthesis, lipogenesis and ketogenesis in isolated rat hepatocytes. Biochem J 1991;273(Pt 1):57-62.
9. Verrey F. System L: heteromeric exchangers of large, neutral amino acids involved in directional transport Pflugers Arch 2003;445:529-533. (Pubitemid 36286884)
10. Nicklin P, Bergman P, Zhang B, Triantafellow E, Wang H, Nyfeler B et al. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 2009;136:521-534.
11. Chotechuang N, Azzout-Marniche D, Bos C, Chaumontet C, Gausseres N, Steiler T et al. mTOR, AMPK, and GCN2 coordinate the adaptation of hepatic energy metabolic pathways in response to protein intake in the rat Am J Physiol Endocrinol Metab 2009;297:E1313-E1323.
12. Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009;9:311-326.
13. Saha AK, Xu XJ, Lawson E, Deoliveira R, Brandon AE, Kraegen EW et al. Downregula-tion of AMPK accompanies leucine-and glucose-induced increases in protein syn-thesis and insulin resistance in rat skeletal muscle. Diabetes 2010;59:2426-2434.
14. Schadewaldt P, Wendel U. Metabolism of branched-chain amino acids in maple syrup urine disease. Eur J Pediatr 1997;156(Suppl. 1):S62-S66.
15. Romano S, Valayannopoulos V, Touati G, Jais JP, Rabier D, de Keyzer Y et al. Cardi-omyopathies in propionic aciduria are reversible after liver transplantation. J Pediatr 2010;156:128-134.
16. de Keyzer Y, Valayannopoulos V, Benoist JF, Batteux F, Lacaille F, Hubert L et al. Mul-tiple OXPHOS deficiency in the liver, kidney, heart, and skeletal muscle of patients with methylmalonic aciduria and propionic aciduria. Pediatr Res 2009;66:91-95.
17. De Bie I, Nizard SD, Mitchell GA. Fetal dilated cardiomyopathy: an unsuspected pres-entation of methylmalonic aciduria and hyperhomocystinuria, cblC type. Prenat Diagn 2009;29:266-270.
18. Arn P, Funanage VL 3-Methylglutaconic aciduria disorders: the clinical spectrum increases. J Pediatr Hematol Oncol 2006;28:62-63.
19. Bowles KR, Bowles NE. Genetics of inherited cardiomyopathies. Expert Rev Cardiovasc Ther 2004;2:683-697. (Pubitemid 39255533)
20. Draaisma JM, van Kesteren IC, Daniels O, Sengers RC. Dilated cardiomyopathy with 3-methylglutaconic aciduria. Pediatr Cardiol 1994;15:89-90. (Pubitemid 24091997)
21. Harris RA, Joshi M, Jeoung NH. Mechanisms responsible for regulation of branched-chain amino acid catabolism. Biochem Biophys Res Commun 2004;313:391-396. (Pubitemid 37543598)
22. Lu G, Ren S, Korge P, Choi J, Dong Y, Weiss J et al. A novel mitochondrial matrixserine/threonine protein phosphatase regulatesthe mitochondria permeabilitytransition pore and is essential for cellular survival and development. Genes Dev 2007;21:784-796. (Pubitemid 46572358)
23. Lu G, Sun H, She P, Youn JY, Warburton S, Ping P et al. Protein phosphatase 2Cm is a critical regulator of branched-chain amino acid catabolism in mice and cultured cells. J Clin Invest 2009;119:1678-1687.
24. Proud CG. Regulation of mammalian translation factors by nutrients. Eur J Biochem 2002;269:5338-5349. (Pubitemid 35365523)
25. Xu G, Kwon G, Cruz WS, Marshall CA, McDaniel ML. Metabolic regulation by leucine oftranslation initiation through the mTOR-signaling pathway by pancreatic beta-cells. Diabetes 2001;50:353-360. (Pubitemid 32127292)
26. Zhang D, Contu R, Latronico MV, Zhang J, Rizzi R, Catalucci D et al. MTORC1 regu-lates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. J Clin Invest 2010;120:2805-2816.
27. Katta A, Kundla S, Kakarla SK, Wu M, Fannin J, Paturi S et al. Impaired overload-induced hypertrophy is associated with diminished mTOR signaling in insulin-resistant skeletal muscle of the obese Zucker rat Am J Physiol Regul Integr Comp Physiol 2010;299:R1666-R1675.
28. Hill JA. Autophagy in cardiac plasticity and disease. Pediatr Cardiol 2011;32:282-289.
29. Aviv Y, Shaw J, Gang H, Kirshenbaum LA. Regulation of autophagy in the heart: 'You Only Live Twice'. Antioxid Redox Signal 2011; doi:10.1089/ars.2010. 3479. Published online ahead of print 7 January 2011.
30. Sciarretta S, Hariharan N, Monden Y, Zablocki D, Sadoshima J. Is Autophagy in response to ischemia and reperfusion protective or detrimental for the heart? Pediatr Cardiol 2010;32:275-281.
31. Zhu H, Rothermel BA, Hill JA. Autophagy in load-induced heart disease. Methods Enzymol 2009;453:343-363.
32. Nishida K, Kyoi S, Yamaguchi O, Sadoshima J, Otsu K. The role of autophagy in the heart. Cell Death Differ 2009;16:31-38.
33. Gustafsson AB, Gottlieb RA. Autophagy in ischemic heart disease. Circ Res 2009;104: 150-158.
34. Meijer AJ, Dubbelhuis PF. Amino acid signalling and the integration of metabolism. Biochem Biophys Res Commun 2004;313:397-403. (Pubitemid 37543599)
35. Hinault C, Van Obberghen E, Mothe-Satney I. Role of amino acids in insulin signaling in adipocytes and their potentialto decrease insulin resistance of adipose tissue. J Nutr Biochem 2006;17:374-378. (Pubitemid 43729348)
36. Xiao F, Huang Z, Li H, Yu J, Wang C, Chen S et al. Leucine deprivation increases hepatic insulin sensitivity via GCN2/mTOR/S6K1 and AMPK pathways. Diabetes 2011;60:746-756.
37. Nishimura J, Masaki T, Arakawa M, Seike M, Yoshimatsu H. Isoleucine prevents the accumulation of tissue triglycerides and upregulates the expression of PPARalpha and uncoupling protein in diet-induced obese mice. J Nutr 2010;140:496-500.
38. D'Antona G, Ragni M, Cardile A, Tedesco L, Dossena M, Bruttini F et al. Branched-chain amino acid supplementation promotes survival and supports cardiac and skeletal muscle mitochondrial biogenesis in middle-aged mice. Cell Metab 2010;12:362-372.
39. Shah SH, Bain JR, Muehlbauer MJ, Stevens RD, Crosslin DR, Haynes C et al. Associ-ation of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events. Circ Cardiovasc Genet 2010;3:207-214.
40. Skvorak KJ. Animal models of maple syrup urine disease. J Inherit Metab Dis 2009;32: 229-246.